November 7, 2016 / 9:22 PM / 9 months ago

BRIEF-Fate Therapeutics reports Q3 2016 financial results

Nov 7 (Reuters) - Fate Therapeutics Inc

* Fate Therapeutics reports third quarter 2016 financial results

* Q3 revenue $1.0 million versus I/B/E/S view $951,000 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below